chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date since 08-NOV-2014, an unspecified number of patients were vaccinated with a dose of GARDASIL (lot #, expiration date, dose and route of administration were not reported) that was exposed to supported temperature excursions. No adverse experience has been reported. This is one of several reports from the same reporter. Additional information has been requested.
In April 2022 when I visited the eye doctor, I had a visual acuity test and they told me I had glaucoma.  My dad also had glaucoma.
Patient was given a COVID-19 vaccine not authorized for their age group. Patient was monitored for 15 minutes after the injection and no side effects were observed at that time. To this date, patient and/or guardian have not reported any side effects or symptoms since being vaccinated. Patient has since completed the vaccination series as recommended which can be found on the COVID-19 Administration Errors and Deviations document. A discussion has occurred about how the error took place and strategies have been implemented to ensure that the error does not happen again.
inadvertently injected an 8.5 week old with BEXSERO; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 8-week-old male patient who received Men B NVS (Bexsero) (batch number ABXA93AA, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd December 2020, the patient received Bexsero (intramuscular) .5 ml and Bexsero Pre-Filled Syringe Device. On 3rd December 2020, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional information was provided as follows: The medical assistant mentioned that, she inadvertently injected an 8.5 week old with Bexsero instead of Hepatitis B in the left thigh, which led to wrong vaccine administered. No further information was provided. The reporter consented to follow up.
1530 Large amount of redness noted on Rt. arm decending to elbow.  Child A&0x3. Denies any SOB or difficulty breathing.  No hives noted. No other redness noted.  Ice pack given.  1535 Redness continues to increase. Benadry 25mg one po given. 1545 Redness on arm continues to increase. Hives noted on trunk of child. Child continues to deny SOB, itching, cough, rhinitis, or difficulty breathing.  Called Dr.and updated.  Orders received to administer 0.3ml of epi sq. 1547 0.3ml of epi administered as ordered. 1550 Bp 118/60 p.80 R.20 easy and non labored. Child continues to deny and SOB or difficulty breathing. Breath sounds clear bilt. all lung fields upon auscultation. 1555 P.88 Child a&ox3. color pale. Skin dry. Continues to deny and no SOB or difficulty breathing noted. 1558 Bp 98/50 P.104. Color improving. 1609 P. 104 Bp90/48. Redness decreasing. 1635 Bp 116/50 P. 102 Child talking without difficulty. Continues to deny and difficulties breathing. Skin w/d and pink. Hives fading. Redness on arm decreasing. 1636 Released.
This spontaneous report as received from a medical assistant refers to a 4 year old patient of unknown gender. Patient's medical history and concurrent conditions were not reported. ON 21-MAY-2015, the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX lot number K021487 (dose and route were not reported) and a dose of improperly stored M-M-R II lot number reported as 014833 (dose and route were not reported). Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports from the same reporter source.  Lot number 014833 is not valid lot number for the M-M-R II. Additional information has been requested.
Localized super infection occurred 11 days after first receiving vaccine. Diagnosed with asthma soon after and hospitalized for the first time on 2/13 for severe respiratory complications. Prescribed nebulizer treatment at home with albuteral, montekulast, prednisone, and qvar inhaler. Went to urgent care today  in hopes to avoid hospital bills. Chest xray showed some fluid. Prescribed iputropium for my nebulizer treatment and also azithromyacin to stall any infection. Lets hope no more hospital visits. Waiting to hear back from pulmonologist to schedule appt.
After the 15 minutes of waiting for any s/s to vaccine, patient became unconscious and pale; vasovagal
Swelling, redness, induration in right thigh, where DTaP and IPV were administered.
Patient history of dementia.  Patient seen in the ED on 11/27/22 with weakness. Patient tested positive for COVID-19 on 11/25 at his living facility after developing a cough and chest congestion. The morning of 11/27, patient's wife found the patient on the floor and was concerned about his weakness. Repeat COVID PCR test in the ED on 11/27 also positive. Ultimately, patient admitted 11/27/22 for acute hypoxic respiratory failure due to COVID-19 infection. He did require supplemental O2 during his admission, however, was able to be weaned off and tolerating room air by discharge. Patient discharged 12/3/22.
SO the following day I was extremely tired and nauseous. I was shaky didn't have much of an appetite either. Those symptoms lasted for about two days, I was also a little bit out of breath and I thought at the time that it was just my asthma flaring up. On Sunday I contacted the employee health and talked to them about it and they told me it was "normal". I saw them in the beginning of February, I couldn't walk 50 steps in my living room without my chest getting really tight, they said not to worry about it and that it was "normal". My Oxygen levels were also going low like 91/92 for my blood oxygen levels. My pulse would go up to 102 at the lowest and jump up to 160/170 just to walk from my couch to my kitchen. That and the oxygen dropping lasted for 2 to 2.5 weeks. I also got a Covid test and that was negative.
Pt received FLUMIST at 2:20. Pt (2:25p) became diaphoretic and complained of dizziness. O2 applied VS BP 80/62 P 90 Resp:20 Transported to hospital via ambulance.
Pt experienced cellulitis the day after getting vaccinated. He was treated by the emergency department. He also had a fever.
Initial and follow up information has been received from a physician concerning a 14 year old female student with possible penicillin allergy who on 02-APR-2007 was vaccinated IM with a first dose 0.5 mL of Gardasil lot # 655205/1426F. On 02-APR-2007 the patient developed swollen eyes after receiving the injection. On 03-APR-2007 the patient was seen in the emergency room (E.R.) for swollen eyes and itching and was given BENADRYL intravenous (IV) and ATERAX by mouth (PO). No abnormality of the eye found. On 05-APR-2007 the patient recovered. In follow up it was indicated that on 03-APR-2007, at AM patient developed swollen eyes and itching. She was seen in the emergency room (E.R.) on 03 APR-2007 and no abnormality of the eyes found. She was given treatment of BENADRYL intravenous (IV) and ATERAX by mouth. On 05-APR-2007 patient recovered. Additional information is not expected.
51 y/o male, BMI 37.7, PMHx of HTN and hypolipidemia, admitted for diarrhea, fever, and generalized weakness on 7/19/21. Pt just returned from 4 weeks stay from traveling and symptoms began the day after he got back. Pt presented with AKI. Pt treated with IV antibiotics and IV fluids. Pt was discharged to home on 7/21/21.
Vaccinated while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant) in a 36-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Social alcohol drinker from 2005 to 14-Sep-2020. Concurrent medical conditions included Sleep disorder (Stable at conception) since 2016. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for Sleep disorder.    On 05-Jan-2021 at 9:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Aug-2020 and the estimated date of delivery was 26-May-2021. On 05-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  On 05-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Company Comment: This is a case of product exposure during pregnancy with no associated AEs for this 36-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jan-2021: Internal review on 20JUL2021 resulted in updates to pregnancy details.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 36-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
nausea & stiff neck;nausea only lasted until early AM 9MAY96, neck remained stiff until late PM;today all sx have subsided
Arm was sore for days better that than shingles; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 29-JUL-2022 Reporter's Comments: The case was received from the patient via interactive digital media. The patient got first shot a few weeks ago from reporting and his/her arm was sore for days better that than shingles.  The patient's second shot on the 22nd (unspecified). Additional Supportive Information: Follow-up would not possible as no contact details were available.
On 7/26/02: Received phone call from client's mother re: reaction. On 7/17/02, client's right upper arm became swollen to elbow and arm warm. On 7/18/02, right upper arm swelling spread to wrist. No other symptoms. On 7/20/02, right arm swelling decreased and developed round red clusters on face and hands with swelling above knee to ankles. Skin warm to touch. Advised to see MD.
This case was reported by a consumer and described the occurrence of influenza-like symptoms in a adult female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of influenza like illness (1st dose received on an unknown date, for tolerance refer case US2018GSK167275). In August 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced influenza-like symptoms, local reaction, pain in arm and skin lesion. On an unknown date, the outcome of the influenza-like symptoms, local reaction and pain in arm were unknown and the outcome of the skin lesion was not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, local reaction, pain in arm and skin lesion to be related to SHINGRIX. Additional details were provided as follows: The patient received the 2nd dose of SHINGRIX about 3 weeks before the date of reporting. The patient had flu-like symptoms and a local reaction. The patient also experienced arm soreness which was persistent and a lesion that looked very much like the remnants of her smallpox vaccine. Since it had been three weeks, the patient wanted to know if this was normal and would it resolve or she needed to see her physician.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No current conditions, medical history, concomitant medication were reported. On 07-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with  lot # L007720 Expiration date of 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). On unspecified dates, the PNEUMOVAX 23 had six temperature excursions of 0 Celsius Degrees (32 Fahrenheit) for 328 hours, 0.55 Celsius Degrees (33 Fahrenheit) for 128 hours, -1.11 Celsius Degrees (30 Fahrenheit) for 288 hours, -1.66 Celsius Degrees (29 Fahrenheit) for 256 hours, -0.55 Celsius Degrees (31 Fahrenheit) for 552 hours, and 1.11 Celsius Degrees (34 Fahrenheit) for 72 hours, respectively. The vaccine status was reported as "in excursion" and the type of excursion and storage criteria were reported as "refrigerator (R)". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Body aches, headache, injection site pain, arm pit of arm injected was extremely sore, fatigue, nauseous, dizziness,
Patient is fully vaccinated. Presented to the ED and is COVID +. Patient is a 38-year-old female presenting with Covid symptoms. She's been having symptoms for 3 days. They include fevers, chills, cough, shortness of breath, body aches, fatigue, nausea, vomiting. Denies abdominal pain or chest pain. She was vaccinated and had the booster. She does work at the hospital so does have Covid exposures.Symptoms were worse today. BP 133/62  | Pulse (!) 123  | Temp (!) 103.1 °F (39.5 °C) (Oral)  | Resp 20  | Ht 172.7 cm (5' 8")  | Wt 97.5 kg (215 lb)  | LMP 12/13/2021  | SpO2 99%  | BMI 32.69 kg/m² Patient was given Tylenol, Zofran, IV fluids, Toradol. Magnesium 1.6, replacement given. Chest x-ray no acute process per radiology.  Stable and discharged.  Referral for monoclonal antibody infusion.  d dimer 943
Patient contacted me on 12/23/20. She advised starting 12/22 soreness and redness at injection site and on 12/23/20 she started with fever. Fever went up to 102.
Soaking through 10+ diapers per day, drinking a lot more, more lethargic. Admitted to Hospital with diabetic ketoacidosis and diagnosed with new onset insulin-dependent diabetes mellitus.
Initial case was received on 24 September 2010 from a healthcare professional. A 35 year old female patient received on 21 September 2010 a left deltoid intramuscular injection of FLUZONE SV 2010-2011 (lot number UH182AC). Six hours after the vaccination the patient experienced "the top of her head feeling numb" and left arm from site of injection to fingers "numb and tingling, as if asleep." The next morning (22 September 2010), her left side felt numb and heavy and the right side of her face felt numb. The patient had no illness at the time of the vaccination and no vaccinations within 4 weeks. Pre-existing medical conditions and concomitant medications were unknown. The patient was seen by her physician "who felt it was a vaccine reaction." No further information was provided. The outcome of the adverse event was unknown. Documents held by sender: None.
02/25/2021 Vaccination, 02/26/2021 I had a HA. Achy, tired, soreness. That lasted for about 24 hours. I had more HA between the vaccines, enough that I noticed they were back. It made me recognize because I hadn't had for a while.  10-2020 COVID; COVID HA's. 'Unlike any other vaccine I had had before.
Patient received COVID vaccine on 7/17/21 in another country then received Pfizer COVID vaccine on 8/17/21 in the states. On 8/23/21, patient was admitted to our facility for acute hypoxic respiratory failure due to COVID-19 pneumonia (symptoms started 8/17/21). Patient received remdesivir and dexamethasone 8/24/21-8/28/21. Patient discharged home on 8/29/21 in good condition.
Sudden Hearing Loss; 1st dose 16Mar2021, 2nd dose 22Mar2021; This is a spontaneous report from a contactable consumer (patient) reported that a 73-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 22Mar2021 10:30 (at the age of 73-years-old) as a single dose for covid-19 immunisation. The patient medical history included diabetes from an unknown date. The patient had no covid-19 prior vaccination. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in left arm on 16Mar2021 2:30 PM (at the age of 73-years-old) for covid-19 immunization. The patient experienced sudden hearing loss on 08Apr2021 17:00 with outcome of unknown. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not received any treatment for the event. The outcome of the event was unknown. Not covid-19 tested post vaccination.  Information on the lot/batch number has been requested.
12Apr90 pt vax; devel fever 102.6, rash on neck & face which spread to back, chest, & limbs, exp sens. to light & rubbed eyes.  Rash described as measles.
covid vaccine breakthrough case  All Pfizer dose 1 1/18/21  EL1283 dose 2 2/8/21  EL9269 dose 3 8/26/21  FC3183 dose 4 4/4/22  FM0698
The day after the vaccine I was sitting at work at 11:00am and I got a wave of lightheadedness and nausea. I passed out when I tried to stand and I was taken by ambulance to the ER. There were no identifiable problems. I was 23 weeks pregnant. I still felt a little lethargic for another week and then I was fine. I have not had any other problems.  Due Date- 07/31/2021 Pregnancy-First pregnancy
Issues with her stomach; Doesn't feel great; This case was reported by a consumer via call center representative and described the occurrence of stomach discomfort in a 63-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced stomach discomfort and feeling unwell. On an unknown date, the outcome of the stomach discomfort and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the stomach discomfort and feeling unwell to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information was provided as follows: The case was reported by the patient herself. The age at vaccination was not reported. The patient experienced stomach discomfort and was not feeling well after receiving the Flu vaccinein the past.  The reporter consented to follow up. The case is linked with the case- US2020AMR199016 and case- US2020198047, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020198047:same reporter
1/2 hour post vax, dull pain throughout arm -  moved to shoulder and now have shoulder/shoulder blade pain.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Apr2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 14Jun2021 at 15:00 as dose 2, single (Batch/Lot number: unknown), in left arm and on 30Nov2021 at 14:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "AOSD" (unspecified if ongoing), notes: Was taking Kineret before I caught covid but stopped as symptoms started and have not resumed. There were no concomitant medications and no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) Positive. Therapeutic measures were taken as a result of covid-19 (Paxlovid (anti-viral) initially worked, and symptoms resolved but 5 days after the last dose, all the symptoms came back and 2 weeks later I still am sick and testing positive using an at home antigen test).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache that evening after the injection (Saturday). Sunday was full body aches, very sore arm muscle, headache, nausea. By Tuesday felt much better, but still have arm soreness, injection site redness, and itchiness at injection site as well.
Sore arm; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced MYALGIA (Sore arm). In February 2021, MYALGIA (Sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication included vitamins, thyroid medication.   This case was linked to MOD-2021-227771 (Patient Link).
The pt states that he was ill with nausea, low grade fever post vax. Pt states he hiked 9 miles and muscles were so sore. Pt was not seen and evaluated at time of complaints.